A cost pressure recognition of 2 per cent, forecast to be around $9.6 million, will be paid through the Additional Professional Advisory Services payment, introduced in the new Integrated Community Pharmacy Services Agreement (ICPSA) last year. This is on top of $8.9 million expected underlying growth in 2019/20.
“The APAS payment recognises the clinical services pharmacists provide to their patients that are not specifically linked to the dispensing of a medicine,” Carolyn said.
National funding of $4.1 million for DHBs to use to commission local services to meet specific local needs will continue in 2019/20.
The ICPSA is an evergreen contract - it has no end-date. Current APAS funding expires on 30 September 2019, however DHBs have decided to continue APAS funding for all contract-holders who sign a Variation. Contract-holders will be offered ICPSA Variation 1A, which will give them access to the new APAS funding plus the continuing 2018-19 allocation of $8.4 million.
If they don’t wish to sign Variation 1A, they can still access the 2018-19 APAS allocation of $8.4 million by signing Variation 1B.
“ We have updated the equity adjustor applied to the new APAS funding to better recognise Māori and Pacific people, and Community Service Card and High Use Health Card holders.”
Details of the ICPSA Contract Variations offer can be found on the TAS website at this link.